PB Ratio: 0.05

Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 0.05 is 89% below its estimated 4-year average of 0.45, near the low end of its estimated 4-year range (0.05–7.59).

As of 2026-10-06T21:39:03.770Z. 77.90% below its estimated 12-month average of 0.23.

VRAX PB Ratio Metrics

P/B vs. estimated history

At 0.05, P/B is below its estimated 4-year median — higher than 0% of readings in its estimated 4-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)

The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Virax Biolabs Group Limited (VRAX)?

The P/B ratio for VRAX stock is 0.05.

Is Virax Biolabs Group Limited's P/B ratio high or low?

The P/B ratio of 0.05 is 89% below its estimated 4-year average of 0.45, near the low end of its estimated 4-year range (0.05–7.59).

What is the estimated TTM average P/B ratio for Virax Biolabs Group Limited (VRAX)?

The estimated TTM average P/B ratio for VRAX stock is 0.23.

What is the estimated 3Y average P/B ratio for Virax Biolabs Group Limited (VRAX)?

The estimated 3Y average P/B ratio for VRAX stock is 0.41.

Showing the most recent 260 of 1,005 data points. The chart above shows the full history.

Related Metrics